MarleneMarcelinaSaucedo-‐Balderas&al.
272
10. AGRADECIMIENTOS
Al Consejo Nacional de Ciencia y Tecnología de México (CONACyT) por el
financiamiento(proyecto179674)otorgado.
11. REFERENCIAS
1.
Steed, J.W.; Atwood, J. L.;
SupramolecularChemistry
;SecondEd; JohnWiley&Sons, Ltd.;
UK, 2009; p27.
2.
Almarsson, Ö.; Zaworotko,M. J. Crystal engineeringof thecompositionof pharmaceutical
phases. Dopharmaceutical co-‐crystals represent anewpath to improvedmedicines?
Chem. Comm.
7,
1889-‐1896(2004).
3.
Schultheiss, N.;Newman, A. Pharmaceutical CocrystalsandTheirPhysicochemical
Properties. Cryst. GrowthDes
.
9
, 2950-‐2967(2009).
4.
Mirza, S.;Miroshnyk, I.;Heinämäki, J.; Yliruu, J. Co-‐crystals: Anemergingapproach for
enhancingpropertiesof pharmaceutical solids. Dosis
24
, 90-‐96(2008).
5.
Jones,W.;Motherwell,W. D. S.; Trask, A. V. Pharmaceutical Cocrystals: AnEmerging
Approach toPhysical PropertyEnhancement.MRSBull.
31
, 875-‐879(2006).
6.
Sekhon, B. S. Pharmaceutical co-‐crystals -‐ a review. ARSPharm.
50
, 99-‐117(2009).
7.
HerreraRuiz, D. ¿Qué sabeUd. acercade…los co-‐cristales farmacéuticos?Rev.Mex. Cienc.
Farm.
41
, 55-‐56(2010).
8.
Delori, A.; Friscic, T.; Jones,W. The roleofmechanochemistryandsupramoleculardesign
in thedevelopment of pharmaceuticalmaterials.CrystEngComm
14
, 2350-‐2362(2012).
9.
Prasad, R. V.; Rakesh,M. G.; Jyotsna, R.M.;Mangesh, S. T.; Anita, P. S.;Mayur, P. K.
Pharmaceutical Cocrystallization: AReview. IJPCS.
3
, 725-‐736(2012).
10.
Friscic, T.; Jones,W. RecentAdvances inUnderstanding theMechanismof Cocrystal
FormationviaGrinding. Cryst. GrowthDes.
9
, 1621-‐1637(2009).
11.
Weyna, D. R.; Shattock, T.; Vishweshwar, P.; Zaworotko,M. J. Synthesis andStructural
Characterizationof Cocrystals andPharmaceutical Cocrystals:MechanochemistryvsSlow
Evaporation fromSolution. Cryst. GrowthDes.
9
, 1106-‐1123(2009).
12.
Lin, H.-‐L.;Wu, T.-‐K.; Lin, S.-‐Y. Screeningandcharacterizationof cocrystal formationof
metaxalonewithshort-‐chaindicarboxylicacids inducedbysolvent-‐assistedgrinding
approach. Thermochim. Acta
575
, 313-‐321(2014).
13.
Ober, C. A.;Montgomery, S. E.; Gupta, R. B. Formationof itraconazole/L-‐malicacid
cocrystalsbygas antisolventcocrystallization. PowderTechnol.
236
, 122-‐131(2013).
14.
Aher, S.;Dhumal, R.;Mahadik, K.; Paradkar, A.; York, P. Ultrasoundassisted
cocrystallization fromsolution(USSC) containinganon-‐congruentlysolublecocrystal
component pair: Caffeine/maleicacid. Eur. J. of Pharm. Sci.
41
, 597-‐602(2010).
15.
Padrela, L.; Rodrigues,M. A.; Tiago, J.; Velaga, S. P.;Matos, H. A.; Azevedo, E. G. Tuning
physicochemical propertiesof theophyllinebycocrystallizationusing the supercritical
fluidenhancedatomization technique. J.of Supercritical Fluids
86
, 129-‐136(2014).
16.
Kojima, T.; Tsutsumi, S.; Yamamoto, K.; Ikeda, Y.;Moriwaki, T. High-‐throughput cocrystal
slurryscreeningbyuseof insituRamanmicroscopyandmulti-‐well plate. Int. J. of
Pharm.
399
, 52-‐59(2010).
17.
Nanjwade, V. K.;Manvi, F. V.; Shamrez, A.M.;Nanjwade, B. K.;Maste,M.M. (2011). New
Trends in theCo-‐crystallizationofActivePharmaceutical Ingredients.J. ofAppl. Pharm.
Sci.
1
, 1-‐5.
18.
Ali, H. R. H.; Alhalaweh, A.;Mendes, N. F. C.; Ribeiro-‐Claro, P.;Velaga, S. P. Solid-‐state
vibrational spectroscopic investigationof cocrystals andsalt of indomethacin.
CrystEngComm.
14
, 6665-‐6674(2012).
19.
Castro, R. A. E.; Ribeiro, J. D. B.;Maria, T.M. R.; Silva,M. R.; Yuste-‐Vivas, C.; Canotilho, J.;
Eusebio,M. E. S. NaproxenCocrystalswithPyridinecarboxamide Isomers. Cryst. Growth
Des.
11
, 5396-‐5404(2011).
20.
Bathori, N. B.; Lemmerer, A.; Venter, G. A.; Bourne, S. A.; Caira,M. R. Pharmaceutical Co-‐
crystalswith Isonicotinamide;VitaminB3, ClofibricAcid, andDiclofenac-‐andTwo
IsonicotinamideHydrates. Cryst. GrowthDes.
11
, 75-‐87(2011).
